EcoDrugPlus

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSPCTG00005000648
Gene Symbol: PSMB1
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSPCTG00005004049
Gene Symbol: PSMB2
3 Cross references
220 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSPCTG00005018741
Gene Symbol: PSMB4
3 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSPCTG00005018111
Gene Symbol: PSMB6
3 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSPCTG00005013513
Gene Symbol: PSMB7
1 Cross references
218 Possible Orthologues:

Proteasome 20s Subunit Beta 8

Ensembl ID : ENSPCTG00005021456
Gene Symbol: PSMB8
3 Cross references
220 Possible Orthologues:

Proteasome 26s Subunit, Atpase 3

Ensembl ID : ENSPCTG00005018286
Gene Symbol: PSMC3
1 Cross references
226 Possible Orthologues:

Proteasome 26s Subunit, Atpase 4

Ensembl ID : ENSPCTG00005018340
Gene Symbol: PSMC4
3 Cross references
197 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 1

Ensembl ID : ENSPCTG00005017038
Gene Symbol: PSMD1
3 Cross references
210 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSPCTG00005016575
Gene Symbol: PSMD12
3 Cross references
220 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSPCTG00005011249
Gene Symbol: PSMD14
3 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 3

Ensembl ID : ENSPCTG00005010192
Gene Symbol: PSMD3
3 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).